Drug intelligence / Profile preview

dihematoporphyrin derivative

Development stage
Unknown
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Dihematoporphyrin derivative is a complex mixture of porphyrins derived from hematoporphyrin. It acts as a photosensitizer and is used in photodynamic therapy (PDT) for the treatment of various cancers and certain benign neoplasms. After intravenous administration, it selectively localizes in malignant or rapidly metabolizing tissues. Upon activation by light of a specific wavelength, it generates singlet oxygen and other reactive oxygen species that induce cytotoxicity and tissue destruction at the targeted site[2][6][10]. Its mechanism relies on photoactivation to produce localized oxidative damage. Dihematoporphyrin derivative was one of the first clinically used photosensitizers for PDT[9]. It has also been investigated for bactericidal effects when activated by light[3].

Brand names
Photofrin
Other names
hematoporphyrin derivativeHpDdihematoporphyrin etherPhotofrinBL-1BL1BL 1

Beyond the preview

Go deeper on dihematoporphyrin derivative.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dihematoporphyrin derivative.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call